Potential of epigenetic therapies in the management of solid tumors
about
DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer EpigeneticsIntegration of molecular pathology, epidemiology and social science for global precision medicine.Actionable Intelligence Provided by Pancreatic Cancer Genomic Landscape: Are Targets for Curative Therapy On The Map?Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agentsOngoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report.Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.Role of epigenetic regulation on the induction of apoptosis in Jurkat leukemia cells by white grape pomace rich in phenolic compounds.The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells.
P2860
Q26749421-EF466CCF-F45C-43A5-ACFE-91EF653BA012Q36463854-3A6BF68B-3A1D-4E9E-A303-95449DBC21A7Q37265792-FA9F61AD-6CE6-45CD-9BF5-F57E66AD1454Q37330876-53B81F2C-2464-4F03-98AF-1F6EAAB7AC50Q37642191-CB5FA4B1-2B43-457D-9673-CB6280540C83Q38390185-89F3AFD7-B487-452F-AACF-2932444B2FF4Q38705982-E9B56A6E-F379-4701-8E99-E8E320CF2546Q39275789-DA1DB017-127C-43C0-AF9A-17193191FCFDQ40196443-EFBCCD2D-DCDC-4883-A209-6969185FEE07Q46295217-EB056891-9EB8-46A1-A292-5E0B7FC4FB41Q47115593-E5FD95F9-6FDC-4088-8956-34CC822BAC2FQ48098943-67DDA69E-A357-412F-98BA-552BA676664EQ52366367-AC284CC4-27C6-4451-9FD7-448F833CE64E
P2860
Potential of epigenetic therapies in the management of solid tumors
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Potential of epigenetic therapies in the management of solid tumors
@ast
Potential of epigenetic therapies in the management of solid tumors
@en
Potential of epigenetic therapies in the management of solid tumors
@nl
type
label
Potential of epigenetic therapies in the management of solid tumors
@ast
Potential of epigenetic therapies in the management of solid tumors
@en
Potential of epigenetic therapies in the management of solid tumors
@nl
prefLabel
Potential of epigenetic therapies in the management of solid tumors
@ast
Potential of epigenetic therapies in the management of solid tumors
@en
Potential of epigenetic therapies in the management of solid tumors
@nl
P2860
P3181
P356
P1476
Potential of epigenetic therapies in the management of solid tumors
@en
P2093
Patricia M Valdespino
Victor Valdespino
P2860
P304
P3181
P356
10.2147/CMAR.S70358
P407
P577
2015-01-01T00:00:00Z